,src,lang,text
0,"











Divi's Labs Q2 net down 12% at Rs 357 cr; revenue rises to Rs 1446 cr
The company had posted a net profit of Rs 403.72 crore in the July-September period of 2018-19.
05 Nov 2019, 15:00 by Press Trust of India
Drug firm Divi's Laboratories on Tuesday reported an 11.62 per cent dip in its consolidated net profit at Rs 356.78 crore for the second quarter ended September 30.
The company had posted a net profit of Rs 403.72 crore in the July-September period of 2018-19.
Revenue from operations in the September 2019 quarter, however, rose to Rs 1,445.57 crore as compared with Rs 1,323.93 in the year-ago period, Divi's Laboratories said in a regulatory filing.
The company said its capital expenditure programmes in Hyderabad and Visakhapatnam were going as per schedule and major part of these projects were expected to be completed by the end of the current financial year.


",en,"











Divi's Labs Q2 net down 12% at Rs 357 cr; revenue rises to Rs 1446 cr
The company had posted a net profit of Rs 403.72 crore in the July-September period of 2018-19.
05 Nov 2019, 15:00 by Press Trust of India
Drug firm Divi's Laboratories on Tuesday reported an 11.62 per cent dip in its consolidated net profit at Rs 356.78 crore for the second quarter ended September 30.
The company had posted a net profit of Rs 403.72 crore in the July-September period of 2018-19.
Revenue from operations in the September 2019 quarter, however, rose to Rs 1,445.57 crore as compared with Rs 1,323.93 in the year-ago period, Divi's Laboratories said in a regulatory filing.
The company said its capital expenditure programmes in Hyderabad and Visakhapatnam were going as per schedule and major part of these projects were expected to be completed by the end of the current financial year.


"
